Meet us at CPHI 2023

2023/10/23

Meet us at CPHI 2023 in Barcelona, Booth 3C29 in the Bioproduction area

CPHI creates connections and inspires partnerships across the global pharma community.

Meet our business development experts from October 24-26, 2023 in Barcelona, Spain. Johannes Clemens, Dr. Jörg Müller and Dr. Anja Bürger are looking forward to fruitful conversions and interesting discussions with you.

Meet us at booth no. 3C29 or just contact us right now.

Event Page

Arrange a meeting

Arrange a face-to-face meeting with our experts by contacting Dr. Jörg Müller

Phone: +49 89 41 77 60 – 111
Mail: joerg.mueller@coriolis-pharma.com

News

2023/11/06

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

News

2023/10/16

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

News

2023/09/04

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.

News

2023/07/31

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

News

2023/07/28

Coriolis sponsors GFK sailing team

Coriolis sponsors GFK sailing team at H-Boat World Cup race from August 1-4, 2023, on Lake Garda in Italy. We keep our fingers crossed.

News

2023/07/18

Coriolis contributes to CNAT-M

Coriolis contributes to CNATM with drug product development expertise and formulation know-how to enable the transformation from innovative molecules towards drug products suitable for human application.

News

2023/07/05

Coriolis welcomes delegation from Japan

Last week we had the pleasure to welcome visitors from the Bio-Industry Division of the Japanese Ministry of Economy, Trade and Industry and from U-Medico at our headquarters in Martinsried.

News

2023/02/01

Coriolis Pharma appoints formulation expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board

With the appointment of Reza Nejadnik to its scientific advisory board, Coriolis again strengthens its scientific expertise particularly in the area of protein formulation and analytics.

News

2022/12/06

Coriolis Pharma appoints formulation and drug development expert Bruce Kerwin to scientific advisory board

News

2022/11/24

Constanze Helbig honored by JPharmSci® as Outstanding Early Career Scientist

Constanze Helbig, Group Leader Scientific Research at Coriolis, is one of the outstanding early career scientists, honored by JPharmSci® for their most original and significant scientific findings.